Ascentage Pharma Group Inc.

700 King Farm Blvd, Rockville, Maryland, United States

Clinical Trials

8 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

67.8%

Phase 3

16.9%

Phase 2

11.9%

Early Phase 1

1.7%

Trial Status Distribution

Active, not recruiting

11.9%

Available

1.7%

Completed

15.3%

Not yet recruiting

1.7%

Recruiting

57.6%

Suspended

1.7%

Terminated

8.5%

Withdrawn

1.7%

Clinical Trials

Trials sponsored by this organization (59)

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

Phase 1

Recruiting

interventional

Aug 2026180 participants

A clinical trial to study the effect and safety of an intervention drug in elderly participants with newly diagnosed acute myeloid leukemia

Phase 3

Not yet recruiting

interventional

Mar 2026486 participants

A clinical trial to study the efficacy and safety of a drug in treated patients having chronic lymphocytic leukemia or small lymphocytic lymphoma

Phase 3

Recruiting

interventional

Jan 2026440 participants

Pharmacokinetics of Olverembatinib in Participants With Hepatic Impairment

Phase 1

Recruiting

interventional

Nov 202548 participants

A study to evaluate the efficacy of APG-2575 (Lisaftoclax) plus azacitidine (AZA) vs. placebo plus AZA in newly diagnosed adult subjects with higher risk myelodysplastic syndrome (Higher Risk-MDS).

Phase 3

Recruiting

interventional

Jan 2025490 participants

APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST

Phase 1

Recruiting

interventional

Dec 202490 participants

A Study of Olverembatinib in SDH-deficient GIST.

Phase 3

Recruiting

interventional

Nov 202440 participants

A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus.

Phase 1

Recruiting

interventional

Aug 202440 participants

Page 1 of 8

Approvals

No approval data available

News

No news articles found

Back to Organizations